TIM-3-targeting antibodies and uses thereof
US12122832B2 · kind B2 · utility
0Cited by
14References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2023 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | Jun 7, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are anti-TIM-3 antibodies and antigen-binding fragments, polynucleotides encoding the antibodies and antigen-binding fragments, and pharmaceutical compositions comprising the antibodies and antigen-binding fragments. Uses of the anti-TIM-3 antibodies and antigen-binding fragments described herein in cancer treatment are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.